Achieve Life Sciences, Inc. (ACHV) Social Stream
Achieve Life Sciences Inc (ACHV) Price Targets From Analysts
Use the tables below to see what analysts covering Achieve Life Sciences Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 27 weeks, ACHV's average price target has gone down $6.
Over the past 49 weeks, ACHV's average upside potential has been 387.81%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ACHV Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
ACHV's average broker recommendation rating improved by 0.75 over the prior 39 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ACHV as an investment opportunity.
- Achieve Life Sciences Inc's variance in analysts' estimates is lower than -92.28% of all US stocks.
- In the context of all US stocks, Achieve Life Sciences Inc's upside potential (average analyst target price relative to current price) is greater than 189.19% of them.
- Achieve Life Sciences Inc's average analyst price target is higher than 153.05% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Achieve Life Sciences Inc's number of analysts covering the stock is higher than 128.18% of them.
What is the outlook for ACHV? Use POWR Ratings for clearer insight into price direction.